IIT-WONG-ATB-RANDOMIZED
Phase Early Phase I
OPEN TO ACCRUAL
Inhibition of Oral Tumorigenesis by Antitumor B
NRG-GY022
Phase I
OPEN TO ACCRUAL
Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin